Equities

Shanghai INT Medical Instruments Co Ltd

Shanghai INT Medical Instruments Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (HKD)27.55
  • Today's Change0.25 / 0.92%
  • Shares traded22.80k
  • 1 Year change-0.54%
  • Beta0.2465
Data delayed at least 15 minutes, as of May 31 2024 09:08 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Shanghai INT Medical Instruments Co Ltd, formerly Shanghai Kindly Medical Instruments Co Ltd, is a China-based company principally engaged in the research, development, production and sales of intracardiac interventional devices. The Company operates its businesses through two segments. The Intracardiac Interventional Business segment is mainly engaged in the sales, manufacturing and research and development of intracardiac interventional medical devices and related molds, standard parts and masks. The Other segment is engaged in the research and development of other interventional medical devices, such as neurointerventional medical devices and heart valve implantable medical devices. The Company mainly operates its businesses in the domestic market and overseas markets.

  • Revenue in HKD (TTM)813.79m
  • Net income in HKD169.12m
  • Incorporated2006
  • Employees1.57k
  • Location
    Shanghai INT Medical Instruments Co LtdNo.925 Jinyuan One RoadJiading DistrictSHANGHAI ChinaCHN
  • Phone+86 2 159140056
  • Fax+86 2 169000013
  • Websitehttps://www.int-medical.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Venus MedTech HangZhou Inc531.16m-760.73m2.48bn865.00--0.785--4.67-1.74-1.741.217.160.10140.94021.65614,052.60-15.04-13.20-17.41-14.9779.2179.51-148.37-152.831.86-8.780.2206--20.8933.6233.46--58.20--
Gaush Meditech Ltd1.52bn187.57m2.57bn869.0013.701.419.551.691.271.2710.2712.280.50572.348.851,749,240.006.22--8.35--49.18--12.30--1.195.900.2814--12.16--149.63------
Zylox-Tonbridge Medical Technolgy Co Ltd570.48m-85.11m3.67bn765.00--1.09--6.43-0.259-0.2591.7410.170.15920.9991480.65745,728.10-2.38---2.56--72.95---14.92--4.88--0.018--57.97--30.66------
OrbusNeich Medical Group Holdings Ltd1.20bn352.35m3.93bn1.25k11.231.3710.213.270.42320.42321.443.480.40431.344.38963,017.5011.84--12.86--69.22--29.29--8.60--0.0198--12.45--143.76------
Modern Dental Group Ltd3.17bn404.10m4.32bn7.04k10.741.647.901.360.42450.42453.332.780.84689.105.49450,895.3010.747.0512.608.3453.6150.7712.689.242.5313.170.243839.9812.086.5083.3036.462.42--
Shanghai Conant Optical Co Ltd1.90bn353.50m4.74bn2.51k13.403.1411.382.490.82860.82864.463.530.93282.166.48758,112.8017.3412.5722.4018.6937.4035.2718.5814.642.15--0.133518.5712.7015.5631.5633.0413.49--
Shanghai INT Medical Instruments Co Ltd813.79m169.12m4.85bn1.57k27.942.6322.345.960.9860.9864.7410.480.39042.227.75519,328.007.958.639.499.7658.1959.4420.3526.161.88--0.053531.8028.5029.9618.7921.7645.75--
Lepu Scientch Mdcl Tchnlgy Shnghi Co Ltd352.28m163.80m5.49bn219.0033.532.6430.5015.590.47240.47241.026.010.17170.584810.301,608,590.007.98--8.25--88.62--46.50--22.93--0.0013--31.58--864.81------
AK Medical Holdings Ltd1.18bn196.85m5.62bn1.05k28.492.1719.044.750.17580.17581.062.300.37870.84062.381,123,976.006.309.277.5211.2861.6665.0616.6521.782.77--0.043122.653.9712.74-11.074.6721.675.88
Data as of May 31 2024. Currency figures normalised to Shanghai INT Medical Instruments Co Ltd's reporting currency: Hong Kong Dollar HKD

Institutional shareholders

16.80%Per cent of shares held by top holders
HolderShares% Held
China Orient Asset Management Co. Ltd. (Investment Management)as of 21 May 202413.56m13.01%
UBS Asset Management (Hong Kong) Ltd.as of 29 Feb 20243.10m2.97%
State Board of Administration of Florida Retirement Systemas of 30 Jun 2023428.60k0.41%
Dimensional Fund Advisors LPas of 09 May 2024276.40k0.27%
Fullgoal Fund Management Co., Ltd.as of 30 Jun 202358.20k0.06%
Grandeur Peak Global Advisors LLCas of 31 Jul 202336.20k0.04%
Allianz Global Investors Asia Pacific Ltd.as of 30 Apr 202426.60k0.03%
Dimensional Fund Advisors Ltd.as of 31 Mar 202415.82k0.02%
TimesSquare Capital Management LLCas of 28 Mar 20244.70k0.01%
DFA Australia Ltd.as of 31 Dec 2023833.000.00%
More ▼
Data from 31 Dec 2023 - 30 May 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.